Skip to main content

Table 3 Clinical data on patients 20–65 years who participated in this study on adaptation to newly diagnosed rheumatoid arthritis (n = 95)

From: What predicts negative effects of rheumatoid arthritis? A follow-up two years after diagnosis

Variable PSP, baseline PSP, 24 months Diff within group NPSP, baseline NPSP, 24 months Diff within group Diff of Δ-values between groups Diff at baseline Diff at 24 months
  (n = 41)   p-values* (n = 54)   p-values* p-values* p-values* p-values*
Other important disease 16 (39%)    24 (45%)     0.54  
DAS-28 5.67 (4.72–6.36) 3.30 (2.45–4.34) <0.001 5.09 (49–5.66) 3.08 (2.18–3.86) <0.001 0.39 0.023 0.26
HAQ 1.13 (0.75–1.50) 0.63 (0.38–1.00) <0.001 1.00 (0.63–1.25) 0.25 (0.00–0.63) <0.001 0.11 0.15 <0.001
Patient-reported global perceived disease activity score 64 (42–77) 37 (20–67) <0.001 44 (24–67) 21 (7–49) <0.001 0.62 0.0024 0.019
Patient-reported pain 62 (45–71) 29 (16–52) <0.001 48.5 (28–66) 18 (5–50) <0.001 0.89 0.028 0.011
Disease activity score (assessed by rheumatologist) 3.0 (3.0–4.0) 2.0 (1.3–2.0) <0.001 3.0 (3.0–3.0) 2.0 (1.0–2.0) <0.001 0.59 0.59 0.43
  1. Results presented as medians (interquartile range). Comparing data at diagnosis (or at 6 months) with at 24 months (or at 18 months).
  2. *P values analyzed within groups by Wilcoxon’s paired test, and between groups Mann–Whitney test.
  3. PSP = Patients with psychosocial problems.
  4. NPSP = Patients with no psychosocial problems.